Effect of varenicline on aspects of inhibitory control in smokers

Psychopharmacology

Volumn 231, Issue 18, 2014, Pages 3771-3785

  Austin, A J ^a   Duka, T ^b   Rusted, J ^b   Jackson, A ^a  

^a UNIVERSITY OF BRIGHTON   (United Kingdom)

^b UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

Addiction; Gambling task; Inhibitory control; Nicotine; Prospective memory; Varenicline

Indexed keywords

NICOTINIC RECEPTOR ALPHA4BETA2; PLACEBO; VARENICLINE; BENZAZEPINE DERIVATIVE; NICOTINIC AGENT; QUINOXALINE DERIVATIVE;

ADULT; ARTICLE; CAMBRIDGE GAMBLING TASK TEST; CONTROLLED STUDY; DELAY DISCOUNTING; DOWN REGULATION; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HUMAN; IMPULSIVENESS; INHIBITION (PSYCHOLOGY); INHIBITORY CONTROL; LATENT PERIOD; MALE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PROSPECTIVE MEMORY TEST; PROTEIN FUNCTION; RAPID VISUAL INFORMATION PROCESSING TEST; SATIETY; SMOKING CESSATION; SMOKING HABIT; STOP SIGNAL TEST; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; EXECUTIVE FUNCTION; PROCEDURES; PROSPECTIVE STUDY; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; REACTION TIME; SMOKING; TOBACCO USE DISORDER; YOUNG ADULT;

ADULT; BENZAZEPINES; DOUBLE-BLIND METHOD; EXECUTIVE FUNCTION; FEMALE; HUMANS; INHIBITION (PSYCHOLOGY); MALE; NEUROPSYCHOLOGICAL TESTS; NICOTINIC AGONISTS; PROSPECTIVE STUDIES; QUINOXALINES; REACTION TIME; SMOKING; SMOKING CESSATION; TOBACCO USE DISORDER; YOUNG ADULT;

EID: 84906933915     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-014-3512-7     Document Type: Article

References (80)

1. Aron AR (2011) From reactive to proactive and selective control: developing a richer model for stopping inappropriate responses. Biol Psychiatry 69:55-68
2. Bekker EM, Bocker KB, Van Hunsel F, van den Berg MC, Kenemans KL (2005) Acute effects of nicotine on attention and response inhibition. Pharmacol Biochem Behav 82:539-548 (Pubitemid 41827597)
3. Bickel WK, Odum AL, Madden GJ (1999) Impulsivity and cigarette smoking: delay discounting in current, never, and ex-smokers. Psychopharmacology (Berl) 146:447-454 (Pubitemid 29513285)
4. Blondel A, Sanger DJ, Moser PC (2000) Characterisation of the effects of nicotine in the five-choice serial reaction time task in rats: antagonist studies. Psychopharmacology (Berl) 149:293-305 (Pubitemid 30262344)
5. Brooks DDS, Jackson A (2008) Behavioural differences in impulsivity amongst chippers and regular smokers. J Psychopharmacol 22:A68
6. Bushnell PJ, Levin ED, Marrocco RT, Sarter MF, Strupp BJ, Warburton DM (2000) Attention as a target of intoxication: insights and methods from studies of drug abuse. Neurotoxicol Teratol 22:487-502
7. Coe JW, Brooks PR, Vetelino MG, Wirtz MC, Arnold EP, Huang J, Sands SB, Davis TI, Lebel LA, Fox CB, Shrikhande A, Heym JH, Schaeffer E, Rollema H, Lu Y, Mansbach RS, Chambers LK, Rovetti CC, Schulz DW, Tingley FD 3rd, O'Neill BT (2005) Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation. J Med Chem 48:3474-3477 (Pubitemid 40664098)
8. Cohen JR, Lieberman MD (2010) The common neural basis of exerting self-control in multiple domains. In: Hassin R, Ochsner K, Trope Y (eds) Self control in society, mind and brain. Oxford University Press, New York, pp 141-162
9. Cox LS, Tiffany ST, Christen AG (2001) Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine Tob Res 3:7-16 (Pubitemid 32611534)
10. Coxon J, Van Impe A, Wenderoth N, Swinnen S (2012) Aging and inhibitory control of action: cortico-subthalamic connection strength predicts stopping performance. J Neurosci 32:8401-8412
11. Dawkins L, Powell JH, West R, Powell J, Pickering A (2007) A double-blind placebo-controlled experimental study of nicotine: II - effects on response inhibition and executive functioning. Psychopharmacology (Berl) 190:457-467 (Pubitemid 46204463)
12. Dawkins L, Powell JH, Pickering A, Powell J, West R (2009) Patterns of change in withdrawal symptoms, desire to smoke, reward motivation and response inhibition across 3 months of smoking abstinence. Addiction 104:850-858
13. Delgado MR, Nystrom LE, Fissell C, Noll DC, Fiez JA (2000) Tracking the hemodynamic responses to reward and punishment in the striatum. J Neurophysiol 84:3072-3077
14. Dougherty DM, Mathias CW, Marsh DM (2003) Laboratory measures of impulsivity. In: Coccaro EF (ed) Aggression: psychiatric assessment and treatment. Dekker, New York, pp 247-265
15. Foulds J, Stapleton J, Swettenham J, Bell N, McSorley K, Russell MA (1996) Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers. Psychopharmacology (Berl) 127:31-38 (Pubitemid 26285680)
16. Gross TM, Jarvik ME, Rosenblatt MR (1993) Nicotine abstinence produces content-specific Stroop interference. Psychopharmacology (Berl) 110:333-336 (Pubitemid 23051135)
17. Grottick AJ, Higgins GA (2000) Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task. Behav Brain Res 117:197-208
18. Hahn B, Shoaib M, Stolerman IP (2002) Nicotine-induced enhancement of attention in the five-choice serial reaction time task: the influence of task demands. Psychopharmacology (Berl) 162:129-137 (Pubitemid 34743952)
19. Harrell PT, Juliano LM (2012) A direct test of the influence of nicotine response expectancies on the subjective and cognitive effects of smoking. Exp Clin Psychopharmacol 20:278-286
20. Hatsukami D, Fletcher L, Morgan S, Keenan R, Amble P (1989) The effects of varying cigarette deprivation duration on cognitive and performance tasks. J Subst Abus 1:407-416
21. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO (1991) The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br J Addict 86:1119-1127
22. Heishman SJ (1998) What aspects of human performance are truly enhanced by nicotine? Addiction 93:317-320
23. Hofmann W, Friese M, Strack F (2009) Impulse and self-control from a dual-systems perspective. Perspect Psychol Sci 4:162-176
24. Hughes JR, Keenan RM, Yellin A (1989) Effect of tobacco withdrawal on sustained attention. Addict Behav 14:577-580 (Pubitemid 19258435)
25. Jackson A, Nesic J, Groombridge C, Clowry O, Rusted J, Duka T (2009) Differential involvement of glutamatergic mechanisms in the cognitive and subjective effects of smoking. Neuropsychopharmacology 34:257-265
26. Jones IW, Wonnacott S (2004) Precise localization of α7 nicotinic acetylcholine receptors on glutamatergic axon terminals in the rat ventral tegmental area. J Neurosci 24:11244-11252 (Pubitemid 39658259)
27. Kaiser S, Wonnacott S (2000) Alpha-bungarotoxin-sensitive nicotinic receptors indirectly modulate [3H]dopamine release in rat striatal slices via glutamate release. Mol Pharmacol 58:312-318 (Pubitemid 30497474)
28. Knott VJ, Millar AM, McIntosh JF, Shah DK, Fisher DJ, Blais CM, Ilivitsky V, Horn E (2011) Separate and combined effects of low dose ketamine and nicotine on behavioural and neural correlates of sustained attention. Biol Psychol 88:83-93
29. Kolokotroni KZ, Rodgers RJ, Harrison AA (2011) Acute nicotine increases both impulsive choice and behavioural disinhibition in rats. Psychopharmacology (Berl) 217:455-473
30. Livingstone PD, Srinivasan J, Kew JNC, Dawson LA, Gotti C, Moretti M, Shoaib M, Wonnacott S (2009) α7 and non-α7 nicotinic acetylcholine receptors modulate dopamine release in vitro and in vivo in the rat prefrontal cortex. Eur J Neurosci 29:539-550
31. Logan GD, Cowan WB, Davis KA (1984) On the ability to inhibit simple and choice reaction time responses: a model and a method. J Exp Psychol Hum Percept Perform 10:276-291
32. Mangan GL (1982) The effects of cigarette smoking on vigilance performance. J Gen Psychol 106:77-83
33. Marchant NL, Trawley S, Rusted JM (2008) Prospective memory or prospective attention: physiological and pharmacological support for an attentional model. Int J Neuropsychopharmacol 11:401-411 (Pubitemid 351482511)
34. Marchant NL, King SL, Tabet N, Rusted JM (2010) Positive effects of cholinergic stimulation favor young APOE epsilon4 carriers. Neuropsychopharmacology 35:1090-1096
35. McColl SL, Burstein AH, Reeves KR, Billing CB Jr, Stolar M, Sellers EM (2008) Human abuse liability of the smoking cessation drug varenicline in smokers and nonsmokers. Clin Pharmacol Ther 83:607-614 (Pubitemid 351417072)
36. McGranahan TM, Patzlaff NE, Grady SR, Heinemann SF, Booker TK (2011) alpha4beta2 nicotinic acetylcholine receptors on dopaminergic neurons mediate nicotine reward and anxiety relief. J Neurosci 31:10891-10902
37. McNair D, Lorr M, Dropplemam L (1971) Profile of mood states. Educational and Industrial Testing Service, San Diego
38. Mehrabian A, Russell JA (1978) A questionnaire measure of habitual alcohol use. Psychol Rep 43:803-806
39. Mihalak KB, Carroll FI, Luetje CW (2006) Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors. Mol Pharmacol 70:801-805 (Pubitemid 44268437)
40. Mocking RJ, Patrick Pflanz C, Pringle A, Parsons E, McTavish SF, Cowen PJ, Harmer CJ (2013) Effects of short-term varenicline administration on emotional and cognitive processing in healthy, non-smoking adults: a randomized, double-blind, study. Neuropsychopharmacology 38:476-484
41. Myers CS, Taylor RC, Salmeron BJ, Waters AJ, Heishman SJ (2013) Nicotine enhances alerting, but not executive, attention in smokers and nonsmokers. Nicotine Tob Res 15:277-281
42. Nesic J, Duka T, Rusted JM, Jackson A (2011) A role for glutamate in subjective response to smoking and its action on inhibitory control. Psychopharmacology (Berl) 216:29-42
43. Nigg JT (2000) On inhibition/disinhibition in developmental psychpathology: views from cognitive and personality psychology and a working inhibition taxonomy. Psychol Bull 126:220-246
44. O'Doherty J, Kringelbach ML, Rolls ET, Hornak J, Andrews C (2001) Abstract reward and punishment representations in the human orbitofrontal cortex. Nat Neurosci 4:95-102 (Pubitemid 32095532)
45. Papke RL, Sanberg PR, Shytle RD (2001) Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes. J Pharmacol Exp Ther 297:646-656 (Pubitemid 32377996)
46. Passetti F, Clark L, Mehta MA, Joyce E, King M (2008) Neuropsychological predictors of clinical outcome in opiate addiction. Drug Alcohol Depend 94:82-91
47. Patterson F, Jepson C, Strasser AA, Loughead J, Perkins KA, Gur RC, Frey JM, Siegel S, Lerman C (2009) Varenicline improves mood and cognition during smoking abstinence. Biol Psychiatry 65:144-149
48. Perkins KA, Sanders M, Fonte C, Wilson AS, White W, Stiller R, McNamara D (1999) Effects of central and peripheral nicotinic blockade on human nicotine discrimination. Psychopharmacology (Berl) 142:158-164 (Pubitemid 29190851)
49. Perkins KA, Lerman C, Fonte C, Mercincavage M, Stitzer ML, Chengappa KN, Jain A (2010) Cross-validation of a new procedure for early screening of smoking medications in humans. Clin Pharmacol Ther 88:109-114
50. Postma P, Kumari V, Sharma T, Hines M, Gray JA (2001) Startle response during smoking and 24 h after withdrawal predicts successful smoking cessation. Psychopharmacology (Berl) 156:360-367 (Pubitemid 32702225)
51. Potter AS, Bucci DJ, Newhouse PA (2012) Manipulation of nicotinic acetylcholine receptors differentially affects behavioral inhibition in human subjects with and without disordered baseline impulsivity. Psychopharmacology (Berl) 220:331-340
52. Powell J, Dawkins L, Davis RE (2002a) Smoking, reward responsiveness, and response inhibition: tests of an incentive motivation model. Biol Psychiatry 51:151-163 (Pubitemid 34127905)
53. Powell J, Tait S, Lessiter J (2002b) Cigarette smoking and attention to signals of reward and threat in the Stroop paradigm. Addiction 97:1163-1170
54. Rhodes JD, Hawk LW Jr, Ashare RL, Schlienz NJ, Mahoney MC (2012) The effects of varenicline on attention and inhibitory control among treatment-seeking smokers. Psychopharmacology (Berl) 223:131-138
55. Rogers RD, Owen AM, Middleton HC, Williams EJ, Pickard JD, Sahakian BJ, Robbins TW (1999) Choosing between small, likely rewards and large, unlikely rewards activates inferior and orbital prefrontal cortex. J Neurosci 19:9029-9038 (Pubitemid 30226722)
56. Rollema H, Chambers LK, Coe JW, Glowa J, Hurst RS, Lebel LA, Lu Y, Mansbach RS, Mather RJ, Rovetti CC, Sands SB, Schaeffer E, Schulz DW, Tingley FD 3rd, Williams KE (2007) Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid. Neuropharmacology 52:985-994 (Pubitemid 46227486)
57. Rusted JM, Trawley S (2006) Comparable effects of nicotine in smokers and nonsmokers on a prospective memory task. Neuropsychopharmacology 31:1545-1549
58. Rusted JM, Graupner L, Tennant A, Warburton DM (1998) Effortful processing is a requirement for nicotine-induced improvements in memory. Psychopharmacology (Berl) 138:362-368 (Pubitemid 28365502)
59. Rusted JM, Trawley S, Heath J, Kettle G, Walker H (2005) Nicotine improves memory for delayed intentions. Psychopharmacology (Berl) 182:355-365 (Pubitemid 41464647)
60. Rusted JM, Sawyer R, Jones C, Trawley SL, Marchant NL (2009) Positive effects of nicotine on cognition: the deployment of attention for prospective memory. Psychopharmacology (Berl) 202:93-102
61. Rusted J, Warburton D (1989) Effects of scopolamine on verbal memory: evidence for failure at retrieval, not acquisition. Neuropsychobiology 21:76-83 (Pubitemid 20005887)
62. Schilstrom B, Fagerquist MV, Zhang X, Hertel P, Panagis G, Nomikos GG, Svensson TH (2000) Putative role of presynaptic α7 nicotinic receptors in nicotine stimulated increases of extracellular levels of glutamate and aspartate in the ventral tegmental area. Synapse 38:375-383
63. Shiffman SM (1979) The tobacco withdrawal syndrome. NIDA Res Monogr 23:158-184
64. Shiffman SM, Jarvik ME (1976) Smoking withdrawal symptoms in two weeks of abstinence. Psychopharmacology (Berl) 50:35-39
65. Shiffman S, Johnston JA, Khayrallah M, Elash CA, Gwaltney CJ, Paty JA, Gnys M, Evoniuk G, DeVeaugh-Geiss J (2000) The effect of bupropion on nicotine craving and withdrawal. Psychopharmacology (Berl) 148:33-40 (Pubitemid 30062470)
66. Shiffman S, Waters A, Hickcox M (2004) The nicotine dependence syndrome scale: a multidimensional measure of nicotine dependence. Nicotine Tob Res 6:327-348 (Pubitemid 38678863)
67. Shimamura AP, Janowsky J, Squire LR (1991) What is the role of frontal lobe damage in memory disorders? In: Levin HS, Eisenberg HM, Benton AL (eds) Frontal lobe function and dysfunction. Oxford University Press, New York, pp 173-195
68. Shoaib M, Stolerman IP, Kumar RC (1994) Nicotine-induced place preferences following prior nicotine exposure in rats. Psychopharmacology (Berl) 113:445-452 (Pubitemid 24150492)
69. Snyder FR, Davis FC, Henningfield JE (1989) The tobacco withdrawal syndrome: performance decrements assessed on a computerized test battery. Drug Alcohol Depend 23:259-266 (Pubitemid 19148670)
70. Sofuoglu M, Herman AI, Mooney M, Waters AJ (2009) Varenicline attenuates some of the subjective and physiological effects of intravenous nicotine in humans. Psychopharmacology (Berl) 207:153-162
71. Stoops WW, Vansickel AR, Glaser PE, Rush CR (2008) The influence of acute varenicline administration on smoking and eating behavior in humans. Pharmacol Biochem Behav 91:165-169
72. Tanabe J, Crowley T, Hutchison K, Miller D, Johnson G, Du YP, Zerbe G, Freedman R (2008) Ventral striatal blood flow is altered by acute nicotine but not withdrawal from nicotine. Neuropsychopharmacology 33:627-633
73. Townshend JM, Duka T (2005) Binge drinking, cognitive performance and mood in a population of young social drinkers. Alcohol Clin Exp Res 29:317-325 (Pubitemid 40446122)
74. Tsutsui-Kimura I, Ohmura Y, Izumi T, Yamaguchi T, Yoshida T, Yoshioka M (2010) Nicotine provokes impulsive-like action by stimulating alpha4beta2 nicotinic acetylcholine receptors in the infralimbic, but not in the prelimbic cortex. Psychopharmacology (Berl) 209:351-359
75. Warburton DM, Wesnes K, Shergold K, James M (1986) Facilitation of learning and state dependency with nicotine. Psychopharmacology (Berl) 89:55-59 (Pubitemid 16062962)
76. Watkins SS, Koob GF, Markou A (2000) Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal. NicotineTob Res 2:19-37
77. Wesnes K, Warburton DM (1984) Effects of scopolamine and nicotine on human rapid information processing performance. Psychopharmacology (Berl) 82:147-150 (Pubitemid 14184530)
78. West R, Baker CL, Cappelleri JC, Bushmakin AG (2008) Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt. Psychopharmacology 197:371-377
79. West R, Russell MA (1988) Loss of acute nicotine tolerance and severity of cigarette withdrawal. Psychopharmacology (Berl) 94:563-565 (Pubitemid 18087411)
80. Zack M, Belsito L, Scher R, Eissenberg T, Corrigall WA (2001) Effects of abstinence and smoking on information processing in adolescent smokers. Psychopharmacology (Berl) 153:249-257 (Pubitemid 32127895)